A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

Inclusion Criteria: * Phase II : People ≥ 7 years old * Phase II : Willing to provide identification documents * Phase II : Volunteers must obtain informed consent from the volunteers themselves and/or their guardians/ or delegates, sign the informed consent form and be willing to comply with the requirements of the clinical trial protocol, and be able to complete the full study follow-up * Phase II : Volunteers aged 7\~11 years have completed 4 doses of vaccine containing DPT * Phase II : ≥12 years old volunteers need to have not received any component vaccine containing DPT within 5 years * Phase III : People ≥6 years old * Phase III : Willing to provide identification documents * Phase III : Volunteers must obtain informed consent from themselves and/or their guardians/ or delegates, sign the informed consent form and be willing to comply with the requirements of the clinical trial protocol, and be able to complete the full study follow-up * Phase III : Volunteers aged 6\~11 years old have completed 4 doses of DPT-containing vaccine in the past * Phase III : Volunteers aged ≥12 years should not have received any vaccine containing any component of DPT within 5 years Exclusion Criteria: * Those who have fever before vaccination, with axillary temperature \>37.0℃; * Females with a positive urine pregnancy test or breastfeeding volunteers, volunteers or their partners who have a pregnancy plan within 6 months; * Suffering from hypertension (systolic blood pressure ≥160mmHg…